Fate Therapeutics Balance Sheet Analysis

Assets, liabilities, and stockholders equity in billions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Fate Therapeutics, Inc. (FATE) - Annual data in billions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Current Assets
Cash and Cash Equivalents0.040.040.440.620.170.220.20
Short-Term Investments0.240.270.370.480.320.000.00
Cash & Short-Term Investments0.280.320.440.620.480.220.20
Accounts Receivable0.000.000.040.010.010.000.00
Inventory0.000.000.000.000.000.000.00
Other Current Assets0.010.010.050.040.000.020.00
Total Current Assets0.290.330.500.630.490.230.21
Non-Current Assets
Property, Plant & Equipment (Net)0.110.160.180.160.100.020.01
Long-Term Investments0.030.000.000.100.000.000.00
Other Non-Current Assets0.010.020.020.020.020.000.00
Total Non-Current Assets0.150.170.200.290.130.060.01
Total Assets0.440.510.710.920.620.300.21
Current Liabilities
Accounts Payable0.010.000.060.050.010.020.02
Short-Term Debt0.010.000.000.000.000.000.00
Accrued Liabilities0.020.030.050.040.020.000.00
Deferred Revenue0.000.000.040.020.020.000.00
Other Current Liabilities0.020.000.010.000.040.000.00
Total Current Liabilities0.040.040.110.080.090.030.03
Non-Current Liabilities
Long-Term Debt0.080.100.100.110.090.030.01
Other Non-Current Liabilities0.010.000.010.020.010.000.00
Total Non-Current Liabilities0.080.100.100.160.150.030.03
Total Liabilities0.120.140.220.240.240.060.05
Stockholders' Equity
Common Stock0.000.000.000.000.000.000.00
Retained Earnings-1.40-1.21-1.05-0.77-0.56-0.38-0.29
Accumulated Other Comprehensive Income0.000.000.000.000.000.000.00
Additional Paid-in Capital1.721.581.541.450.940.630.45
Shares Outstanding0.110.100.100.100.000.000.00
Total Stockholders' Equity0.320.370.480.680.380.240.16
Total Liabilities & Equity0.440.510.710.920.620.300.21